Increasing Dyrk1b levels in the mouse liver enhanced de novo lipogenesis (DNL), fatty acid uptake, and triacylglycerol secretion and caused NASH and hyperlipidemia. This evidence concerns the gene DYRK1B and metabolic dysfunction-associated steatohepatitis.